Leading pelvic-health devices provider American Medical Systems (AMMD) recently launched, in the U.S., its new Conceal Low Profile Reservoir, which is an improvement over its current market leading AMS 700 three-piece inflatable penile prosthesis used for the treatment of erectile dysfunction.
The new Conceal reservoir is compatible with the AMS 700 cylinder and pump set-up and provides the flexibility of a single-size-fits-all configuration that can hold about 65 ml to 100 ml of liquid, based on the particular requirements of the user. This especially designed product provides similar usefulness and reliability as the spherical reservoir currently in use. Conceal may be procured with or without American Medical’s InhibiZone antibiotic treatment.
The company’s penile prosthetic solutions offer a long-term surgical option for males who are unhappy with the outcome of other erectile dysfunction treatment opportunities, such as oral drugs. Its prosthetic treatments have 91%, or higher, user satisfaction rates. Erectile dysfunction afflicts about 30 million males in the U.S. and is exacerbated by diabetes, cardiovascular disease and prostate cancer.
American Medical is a global leader in manufacturing medical devices and procedures for treating health problems of both men and women. In addition to the U.S., the company sells its products in Canada, Asia, Australia, Europe and South America.
American Medical has a strong pipeline and remains focused on rolling out new products to drive growth. Other positive factors are represented by the company’s dominant position in both male and female incontinence markets and a sound balance sheet.
However, American Medical faces stiff competition from much larger players like Boston Scientific (BSX) and Johnson & Johnson (JNJ). Besides, the company is exposed to a significant reimbursement risk and its European markets are yet to recover from the macroeconomic headwinds. We currently have a Neutral long-term rating on American Medical supported by a short-term Zacks #3 Rank.
AMER MED SYS (AMMD): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
JOHNSON & JOHNS (JNJ): Free Stock Analysis Report
Zacks Investment Research
